Sinofn Health
Sinofn Health
As Malaysia undergoes a significant demographic transition, the demand for Foods for Special Medical Purposes (FSMP) is experiencing a paradigm shift. With an aging population and an increased prevalence of non-communicable diseases (NCDs) such as diabetes and hypertension, healthcare systems are prioritizing nutritional intervention as a core component of patient management.
Navigating the Malaysian market requires strict adherence to the National Pharmaceutical Regulatory Agency (NPRA) and the Ministry of Health Malaysia (MOH) guidelines. As an experienced FSMP supplier, SINOFN understands that product registration in Malaysia is not merely about compliance—it is about clinical trust. Our formulations are designed with Halal compliance at the forefront, ensuring local cultural acceptance without compromising the high-science requirements of clinical nutrition.
The global FSMP industry is moving towards Precision Nutrition. The future involves utilizing AI to analyze metabolic markers and suggest specific macro-nutrient admixtures. Our R&D facility, backed by the Chinese Academy of Sciences, is pioneering "Clean Label" clinical nutrition, focusing on:
Founded in 2012 by Mrs. GuoHong Liu, SINOFN bridges the gap between clinical necessity and commercial accessibility. We are not just manufacturers; we are partners in clinical nutrition, dedicated to improving patient outcomes through science-backed, affordable FSMP solutions.
Our Core Competencies:
1. Academic Foundation: Strategic partnership with the Chinese Academy of Sciences.
2. Regulatory Readiness: ISO22000, HACCP, FSSC 22000, and Halal certified production lines.
3. Innovation: A deep pipeline of 25+ patents and 71+ registered trademarks.
A: Yes. We are fully equipped to handle Halal certification and compliance documentation required for import into Malaysia, ensuring your products meet local market expectations.
A: Our R&D center, featuring experts from the Chinese Academy of Sciences and international specialists, provides end-to-end support—from clinical ingredient selection to rapid pilot prototyping.
A: We are designed to scale. Whether you need a small, agile pilot run for market testing or mass manufacturing (500M+ units capacity), our modular production lines are tailored to fit your specific volume.
